Sayenko Kharenko's antitrust team has provided legal
assistance in obtaining merger clearance with the Antimonopoly
Committee of Ukraine (the "AMC") for the
USD 12 billion acquisition by Molson Coors Brewing
Company (Molson Coors) of
(SABMiller) 58 per cent stake in
(MillerCoors), the joint venture formed in the
United States and Puerto Rico by SABMiller and Molson Coors in
2008. As part of the transaction, Molson Coors also gains full
ownership of the SABMiller brand portfolio outside of the USA and
Puerto Rico, and retains the rights to all of the brands currently
in the MillerCoors portfolio for the USA and Puerto Rico, including
REDD's and import brands such as Peroni, Grolsch and Pilsner
This transaction enables Molson Coors to become the third
largest global brewer by enterprise value and the sole owner of
MillerCoors, which will continue to operate as separate business
unit of Molson Coors and will retain its name and headquarters in
Molson Coors is a leading international brewer
delivering extraordinary brands that delight the world's beer
drinkers. It brews, markets and sells a portfolio of leading
premium brands such as Coors Light, Miller Lite, Molson Canadian,
Carling, Staropramen and Blue Moon across The Americas, Europe and
Asia. It operates in Canada through Molson Coors Canada; in the USA
through MillerCoors; across Europe through Molson Coors Europe; and
outside these core markets through Molson Coors International. The
company was listed on the Dow Jones Sustainability World Index for
the past five years and named global Beverage Sector Leader in 2012
and 2013. For the past two years, the company was the only alcohol
producer recognized on the Index for world class sustainability
After examining the proposed transaction, the AMC has concluded
that its implementation poses neither threat to competition nor
significantly limits competition on any product market in
Sayenko Kharenko's antitrust team for the current
transaction included counsel Maksym Nazarenko, associates Julia
Kuyda and Igor Pomaz, and was led by partner Vladimir Sayenko.
* * * * * * * * * *
Sayenko Kharenko enjoys global reputation as a leading
Ukrainian law firm with an internationally oriented full-service
practice. The firm's leading market position builds on
continuous excellence of its highly specialized practice teams.
During the past two years, Sayenko Kharenko collected three of the
most prestigious professional excellence country awards, more
specifically, Law Firm of the Year by each of IFLR European Awards,
Who's Who Legal European Awards and Chambers Europe Award for
Excellence. Most recently, Sayenko Kharenko was crowned Ukraine Law
Firm of the Year by Who's Who Legal 2016, and shortlisted in
Russia, Ukraine & the CIS category by The Lawyer European
Awards 2016 and Ukraine Law Firm of the Year category by Chambers
Europe Awards 2016.
To learn more about Sayenko Kharenko expertise and
experience, please contact
The competition law enforcement in Turkey is based on private and public enforcement pillars. TCA has sole discretion to enforce the Competition Act whereas the litigations initiated by the victims of anti-competitive conduct are seen in private courts.
Daiichi Sankyo İlaç Ticaret Ltd. Şti. ("Daiichi"), a globally active company in the distribution, sale, marketing and importation of pharmaceutical products, and Aksel Ecza Deposu A.Ş. ("Aksel"), a drug wholesaler, entered into a vertical exclusivity agreement ("Agreement").
The Competition Board concluded its investigation with regard to the booking services provided by Booking.com B.V. and by Bookingdotcom Destek Hizmetleri LLC, operating as the Turkish representative of Booking.com.
For the past few years, Turkey has tended to use various trade remedy tools more frequently, thus the number of investigations increases in depth and breadth with the aim of supporting domestic industry...
The CAT in the UK heard on 17 January 2017 an application by Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd to suspend the Competition and Markets Authority's direction to reduce the price of an epilepsy drug.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).